Tokyo, July 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000057999) titled 'Investigation of Finerenone Treatment Effects and Safety' on July 30.
Study Type:
Observational
Primary Sponsor:
Institute - Meitetsu hospital
Condition:
Condition - Type 2 diabetes mellitus
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to evaluate the effectiveness and safety of finerenone in patients with type 2 diabetes mellitus and chronic kidney disease using real-world clinical data, as well as to investigate the impact of concomitant use of SGLT2 inhibitors and ACE inhibitors or ARBs on the effects of finerenone.
Basic objec...